C. S. Hahn, J. M. Dalrymple, J. H. Strauss, and C. M. Rice, Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it., Proc. Natl. Acad. Sci. USA, pp.2019-2023, 1987.
DOI : 10.1073/pnas.84.7.2019

J. D. Poland, C. H. Calisher, T. P. Monath, W. G. Downs, and K. Murphy, Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine, Bull. World Health Organ, vol.59, pp.895-900, 1981.

B. Reinhardt, R. Jaspert, M. Niedrig, C. Kostner, and J. L-'age-stehr, Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection, Journal of Medical Virology, vol.25, issue.2, pp.159-167, 1998.
DOI : 10.1002/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B

M. D. Co, M. Terajima, J. Cruz, F. A. Ennis, and A. L. Rothman, Human Cytotoxic T Lymphocyte Responses to Live Attenuated 17D Yellow Fever Vaccine: Identification of HLA-B35-Restricted CTL Epitopes on Nonstructural Proteins NS1, NS2b, NS3, and the Structural Protein E, NS2b, NS3, and the structural protein E. Virology, pp.151-163, 2002.
DOI : 10.1006/viro.2001.1255

T. P. Monath, F. Guirakhoo, R. Nichols, S. Yoksan, R. Schrader et al., Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax???JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen, The Journal of Infectious Diseases, vol.188, issue.8, pp.1213-1230, 2003.
DOI : 10.1086/378356

D. Tao, G. Barba-spaeth, U. Rai, V. Nussenzweig, C. M. Rice et al., Yellow fever 17D as a vaccine vector for microbial CTL epitopes, The Journal of Experimental Medicine, vol.57, issue.2, pp.201-209, 2005.
DOI : 10.1016/S0022-1759(01)00331-3

J. Banchereau and R. M. Steinman, Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998.
DOI : 10.1038/32588

B. Tassaneetrithep, T. H. Burgess, A. Granelli-piperno, C. Trumpfheller, J. Finke et al., DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells, The Journal of Experimental Medicine, vol.14, issue.7, pp.823-829, 2003.
DOI : 10.1016/S0966-842X(01)02288-0

E. Navarro-sanchez, R. Altmeyer, A. Amara, O. Schwartz, F. Fieschi et al., Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses, EMBO Reports, vol.4, issue.7, pp.723-728, 2003.
DOI : 10.1038/sj.embor.embor866

URL : https://hal.archives-ouvertes.fr/pasteur-01372706

B. Rehermann and M. Nascimbeni, Immunology of hepatitis B virus and hepatitis C virus infection, Nature Reviews Immunology, vol.24, issue.3, pp.215-229, 2005.
DOI : 10.1172/JCI200318509

J. J. Chu and M. L. Ng, Interaction of West Nile Virus with ??v??3 Integrin Mediates Virus Entry into Cells, Journal of Biological Chemistry, vol.279, issue.52, pp.54533-54541, 2004.
DOI : 10.1074/jbc.M410208200

R. G. Van-der-most, J. Corver, and J. H. Strauss, Mutagenesis of the RGD Motif in the Yellow Fever Virus 17D Envelope Protein, Virology, vol.265, issue.1, pp.83-95, 1999.
DOI : 10.1006/viro.1999.0026

P. R. Post, C. N. Santos, R. Carvalho, A. C. Cruz, C. M. Rice et al., Heterogeneity in envelope protein sequence and N-Linked glycosylation among yellow fever virus vaccine strains, Virology, vol.188, issue.1, pp.160-167, 1992.
DOI : 10.1016/0042-6822(92)90745-B

M. Cella, M. Salio, Y. Sakakibara, H. Langen, I. Julkunen et al., Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA, The Journal of Experimental Medicine, vol.14, issue.5, pp.821-829, 1999.
DOI : 10.1006/cyto.1997.0270

I. Fugier-vivier, C. Servet-delprat, P. Rivailler, M. C. Rissoan, Y. J. Liu et al., Measles Virus Suppresses Cell-mediated Immunity by Interfering with the Survival and Functions of Dendritic and T Cells, The Journal of Experimental Medicine, vol.13, issue.6, pp.813-823, 1997.
DOI : 10.1016/0167-5699(95)80043-3

G. Pollara, K. Speidel, L. Samady, M. Rajpopat, Y. Mcgrath et al., Herpes Simplex Virus Infection of Dendritic Cells: Balance among Activation, Inhibition, and Immunity, The Journal of Infectious Diseases, vol.187, issue.2, pp.165-178, 2003.
DOI : 10.1086/367675

U. T. Hacker, T. Jelinek, S. Erhardt, A. Eigler, G. Hartmann et al., In Vivo Synthesis of Tumor Necrosis Factor????? in Healthy Humans after Live Yellow Fever Vaccination, The Journal of Infectious Diseases, vol.177, issue.3, pp.774-778, 1998.
DOI : 10.1086/517806

C. Paludan, D. Schmid, M. Landthaler, M. Vockerodt, D. Kube et al., Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy, Science, vol.307, issue.5709, pp.593-596, 2005.
DOI : 10.1126/science.1104904

A. Mcallister, A. E. Arbetman, S. Mandl, C. Pena-rossi, and R. Andino, Recombinant Yellow Fever Viruses Are Effective Therapeutic Vaccines for Treatment of Murine Experimental Solid Tumors and Pulmonary Metastases, Journal of Virology, vol.74, issue.19, pp.9197-9205, 2000.
DOI : 10.1128/JVI.74.19.9197-9205.2000

N. Bhardwaj, A. Bender, N. Gonzalez, L. K. Bui, M. C. Garrett et al., Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells., Journal of Clinical Investigation, vol.94, issue.2, pp.797-807, 1994.
DOI : 10.1172/JCI117399

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC296160

N. Romani, D. Reider, M. Heuer, S. Ebner, E. Kampgen et al., Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicability, Journal of Immunological Methods, vol.196, issue.2, pp.137-151, 1996.
DOI : 10.1016/0022-1759(96)00078-6

C. Rieser, G. Bock, H. Klocker, G. Bartsch, and M. Thurnher, Prostaglandin E2 and Tumor Necrosis Factor ?? Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production, Journal of Experimental Medicine, vol.183, issue.4, pp.1603-1608, 1997.
DOI : 10.1084/jem.183.4.1447

W. J. Rice and . Spaan, A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication, J. Gen. Virol, vol.84, pp.1261-1268, 2003.

S. M. Amberg and C. M. Rice, Mutagenesis of the NS2B-NS3- mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing, J. Virol, vol.73, pp.8083-8094, 1999.

F. Gotch, J. Rothbard, K. Howland, A. Townsend, and A. Mc-michael, Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2, Nature, vol.326, issue.6116, pp.881-882, 1987.
DOI : 10.1038/326881a0

J. J. Schlesinger, E. E. Walsh, and M. W. Brandriss, Analysis of 17D Yellow Fever Virus Envelope Protein Epitopes Using Monoclonal Antibodies, Journal of General Virology, vol.65, issue.10, pp.1637-1644, 1984.
DOI : 10.1099/0022-1317-65-10-1637

T. J. Chambers, D. W. Mccourt, and C. M. Rice, Yellow fever virus proteins NS2A, NS213, and NS4B: Identification and partial N-terminal amino acid sequence analysis, Virology, vol.169, issue.1, pp.100-109, 1989.
DOI : 10.1016/0042-6822(89)90045-7